Journal of Pharmacology and Experimental Therapeutics: 377 (3)

Index by author

June 01, 2021; Volume 377,Issue 3

A

Acosta, Teeshavi
1. You have access
  Brain Concentrations of Methylone and Its Metabolites after Systemic Methylone Administration: Relationship to Pharmacodynamic Effects
  Nicole Centazzo, Michael R. Chojnacki, Joshua S. Elmore, Raider Rodriguez, Teeshavi Acosta, Masaki Suzuki, Kenner C. Rice, Michael H. Baumann and Marta Concheiro
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 398-406; DOI: https://doi.org/10.1124/jpet.121.000531
Ali, Heba
1. Open Access
  Therapeutic Assessment of Combination Therapy with a Neprilysin Inhibitor and Angiotensin Type 1 Receptor Antagonist on Angiotensin II–Induced Atherosclerosis, Abdominal Aortic Aneurysms, and Hypertension
  Yasir Alsiraj, Sean E. Thatcher, Ching Ling Liang, Heba Ali, Mark Ensor and Lisa A. Cassis
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 326-335; DOI: https://doi.org/10.1124/jpet.121.000525
Alsiraj, Yasir
1. Open Access
  Therapeutic Assessment of Combination Therapy with a Neprilysin Inhibitor and Angiotensin Type 1 Receptor Antagonist on Angiotensin II–Induced Atherosclerosis, Abdominal Aortic Aneurysms, and Hypertension
  Yasir Alsiraj, Sean E. Thatcher, Ching Ling Liang, Heba Ali, Mark Ensor and Lisa A. Cassis
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 326-335; DOI: https://doi.org/10.1124/jpet.121.000525

B

Bartkowski, Darian
1. You have access
  Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease
  Nicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. Carlton
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Baumann, Michael H.
1. You have access
  Brain Concentrations of Methylone and Its Metabolites after Systemic Methylone Administration: Relationship to Pharmacodynamic Effects
  Nicole Centazzo, Michael R. Chojnacki, Joshua S. Elmore, Raider Rodriguez, Teeshavi Acosta, Masaki Suzuki, Kenner C. Rice, Michael H. Baumann and Marta Concheiro
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 398-406; DOI: https://doi.org/10.1124/jpet.121.000531
Bergman, Jack
1. You have access
  Novel Antimuscarinic Antidepressant-like Compounds with Reduced Effects on Cognition
  Chad R. Johnson, Brian D. Kangas, Emily M. Jutkiewicz, Gail Winger, Jack Bergman, Andrew Coop and James H. Woods
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 336-345; DOI: https://doi.org/10.1124/jpet.120.000337
Berner-Hansen, Mark
1. You have access
  Comments on “Pharmacological Characterization of Apraglutide a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist for the Treatment of Short Bowel Syndrome”
  Jolanta Skarbaliene, Bjarne Due Larsen, Mark Berner-Hansen and Adam Steensberg
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 369; DOI: https://doi.org/10.1124/jpet.120.000426
Brice, Nicola L.
1. You have access
  Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease
  Nicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. Carlton
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Burley, J. Russell
1. You have access
  Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease
  Nicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. Carlton
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438

C

Callahan, Michael F.
1. You have access
  Chronic Ca²⁺/Calmodulin-Dependent Protein Kinase II Inhibition Rescues Advanced Heart Failure
  Yixi Liu, Qun Shao, Heng-Jie Cheng, Tiankai Li, Xiaowei Zhang, Michael F. Callahan, David Herrington, Dalane Kitzman, David Zhao and Che-Ping Cheng
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 316-325; DOI: https://doi.org/10.1124/jpet.120.000361
Carlton, Mark B.
1. You have access
  Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease
  Nicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. Carlton
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Cassis, Lisa A.
1. Open Access
  Therapeutic Assessment of Combination Therapy with a Neprilysin Inhibitor and Angiotensin Type 1 Receptor Antagonist on Angiotensin II–Induced Atherosclerosis, Abdominal Aortic Aneurysms, and Hypertension
  Yasir Alsiraj, Sean E. Thatcher, Ching Ling Liang, Heba Ali, Mark Ensor and Lisa A. Cassis
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 326-335; DOI: https://doi.org/10.1124/jpet.121.000525
Centazzo, Nicole
1. You have access
  Brain Concentrations of Methylone and Its Metabolites after Systemic Methylone Administration: Relationship to Pharmacodynamic Effects
  Nicole Centazzo, Michael R. Chojnacki, Joshua S. Elmore, Raider Rodriguez, Teeshavi Acosta, Masaki Suzuki, Kenner C. Rice, Michael H. Baumann and Marta Concheiro
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 398-406; DOI: https://doi.org/10.1124/jpet.121.000531
Chen, Shuang
1. You have access
  circ-Keratin 6c Promotes Malignant Progression and Immune Evasion of Colorectal Cancer through microRNA-485-3p/Programmed Cell Death Receptor Ligand 1 Axis
  Zhipeng Jiang, Zehui Hou, Wei Liu, Zhuomin Yu, Zhiqiang Liang and Shuang Chen
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 358-367; DOI: https://doi.org/10.1124/jpet.121.000518
Chen, Yun
1. You have access
  Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease
  Nicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. Carlton
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Cheng, Che-Ping
1. You have access
  Chronic Ca²⁺/Calmodulin-Dependent Protein Kinase II Inhibition Rescues Advanced Heart Failure
  Yixi Liu, Qun Shao, Heng-Jie Cheng, Tiankai Li, Xiaowei Zhang, Michael F. Callahan, David Herrington, Dalane Kitzman, David Zhao and Che-Ping Cheng
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 316-325; DOI: https://doi.org/10.1124/jpet.120.000361
Cheng, Heng-Jie
1. You have access
  Chronic Ca²⁺/Calmodulin-Dependent Protein Kinase II Inhibition Rescues Advanced Heart Failure
  Yixi Liu, Qun Shao, Heng-Jie Cheng, Tiankai Li, Xiaowei Zhang, Michael F. Callahan, David Herrington, Dalane Kitzman, David Zhao and Che-Ping Cheng
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 316-325; DOI: https://doi.org/10.1124/jpet.120.000361
Cheung, Toni
1. You have access
  Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease
  Nicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. Carlton
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Choi, Young Hee
1. Open Access
  A Novel Integrated Pharmacokinetic-Pharmacodynamic Model to Evaluate Combination Therapy and Determine In Vivo Synergism
  Young Hee Choi, Chao Zhang, Zhenzhen Liu, Mei-Juan Tu, Ai-Xi Yu and Ai-Ming Yu
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 305-315; DOI: https://doi.org/10.1124/jpet.121.000584
Chojnacki, Michael R.
1. You have access
  Brain Concentrations of Methylone and Its Metabolites after Systemic Methylone Administration: Relationship to Pharmacodynamic Effects
  Nicole Centazzo, Michael R. Chojnacki, Joshua S. Elmore, Raider Rodriguez, Teeshavi Acosta, Masaki Suzuki, Kenner C. Rice, Michael H. Baumann and Marta Concheiro
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 398-406; DOI: https://doi.org/10.1124/jpet.121.000531
Ciccarone, Fabio
1. You have access
  Poly(ADP-Ribose) Polymerase Inhibitors for Arsenic Trioxide–Resistant Acute Promyelocytic Leukemia: Synergistic In Vitro Antitumor Effects with Hypomethylating Agents or High-Dose Vitamin C
  Manuela Giansanti, Antonio De Gabrieli, Salvatore Pasquale Prete, Tiziana Ottone, Maria Domenica Divona, Terry Karimi, Fabio Ciccarone, Maria Teresa Voso, Grazia Graziani and Isabella Faraoni
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 385-397; DOI: https://doi.org/10.1124/jpet.121.000537
Clausen, Trine R.
1. Open Access
  AM833 Is a Novel Agonist of Calcitonin Family G Protein–Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective Agonists
  Madeleine M. Fletcher, Peter Keov, Tin T. Truong, Grace Mennen, Caroline A. Hick, Peishen Zhao, Sebastian G.B. Furness, Thomas Kruse, Trine R. Clausen, Denise Wootten and Patrick M. Sexton
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 417-440; DOI: https://doi.org/10.1124/jpet.121.000567
Concheiro, Marta
1. You have access
  Brain Concentrations of Methylone and Its Metabolites after Systemic Methylone Administration: Relationship to Pharmacodynamic Effects
  Nicole Centazzo, Michael R. Chojnacki, Joshua S. Elmore, Raider Rodriguez, Teeshavi Acosta, Masaki Suzuki, Kenner C. Rice, Michael H. Baumann and Marta Concheiro
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 398-406; DOI: https://doi.org/10.1124/jpet.121.000531
Coop, Andrew
1. You have access
  Novel Antimuscarinic Antidepressant-like Compounds with Reduced Effects on Cognition
  Chad R. Johnson, Brian D. Kangas, Emily M. Jutkiewicz, Gail Winger, Jack Bergman, Andrew Coop and James H. Woods
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 336-345; DOI: https://doi.org/10.1124/jpet.120.000337

D

Dawson, Lee A.
1. You have access
  Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease
  Nicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. Carlton
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
De Gabrieli, Antonio
1. You have access
  Poly(ADP-Ribose) Polymerase Inhibitors for Arsenic Trioxide–Resistant Acute Promyelocytic Leukemia: Synergistic In Vitro Antitumor Effects with Hypomethylating Agents or High-Dose Vitamin C
  Manuela Giansanti, Antonio De Gabrieli, Salvatore Pasquale Prete, Tiziana Ottone, Maria Domenica Divona, Terry Karimi, Fabio Ciccarone, Maria Teresa Voso, Grazia Graziani and Isabella Faraoni
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 385-397; DOI: https://doi.org/10.1124/jpet.121.000537
Dickson, Louise
1. You have access
  Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease
  Nicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. Carlton
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Ding, Li-li
1. You have access
  Ginsenoside Ro Ameliorates High-Fat Diet–Induced Obesity and Insulin Resistance in Mice via Activation of the G Protein–Coupled Bile Acid Receptor 5 Pathway
  Lin-shan Jiang, Wei Li, Tong-xi Zhuang, Jie-jing Yu, Shuai Sun, Zheng-cai Ju, Zheng-tao Wang, Li-li Ding and Li Yang
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 441-451; DOI: https://doi.org/10.1124/jpet.120.000435
Divona, Maria Domenica
1. You have access
  Poly(ADP-Ribose) Polymerase Inhibitors for Arsenic Trioxide–Resistant Acute Promyelocytic Leukemia: Synergistic In Vitro Antitumor Effects with Hypomethylating Agents or High-Dose Vitamin C
  Manuela Giansanti, Antonio De Gabrieli, Salvatore Pasquale Prete, Tiziana Ottone, Maria Domenica Divona, Terry Karimi, Fabio Ciccarone, Maria Teresa Voso, Grazia Graziani and Isabella Faraoni
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 385-397; DOI: https://doi.org/10.1124/jpet.121.000537

E

Elmore, Joshua S.
1. You have access
  Brain Concentrations of Methylone and Its Metabolites after Systemic Methylone Administration: Relationship to Pharmacodynamic Effects
  Nicole Centazzo, Michael R. Chojnacki, Joshua S. Elmore, Raider Rodriguez, Teeshavi Acosta, Masaki Suzuki, Kenner C. Rice, Michael H. Baumann and Marta Concheiro
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 398-406; DOI: https://doi.org/10.1124/jpet.121.000531
Ensor, Mark
1. Open Access
  Therapeutic Assessment of Combination Therapy with a Neprilysin Inhibitor and Angiotensin Type 1 Receptor Antagonist on Angiotensin II–Induced Atherosclerosis, Abdominal Aortic Aneurysms, and Hypertension
  Yasir Alsiraj, Sean E. Thatcher, Ching Ling Liang, Heba Ali, Mark Ensor and Lisa A. Cassis
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 326-335; DOI: https://doi.org/10.1124/jpet.121.000525
Euler, Adriana
1. Open Access
  Characterization of Novel Fluorescent Bile Salt Derivatives for Studying Human Bile Salt and Organic Anion Transporters
  Michele Leuenberger, Stephanie Häusler, Vera Höhn, Adriana Euler, Bruno Stieger and Martin Lochner
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 346-357; DOI: https://doi.org/10.1124/jpet.120.000449

F

Faraoni, Isabella
1. You have access
  Poly(ADP-Ribose) Polymerase Inhibitors for Arsenic Trioxide–Resistant Acute Promyelocytic Leukemia: Synergistic In Vitro Antitumor Effects with Hypomethylating Agents or High-Dose Vitamin C
  Manuela Giansanti, Antonio De Gabrieli, Salvatore Pasquale Prete, Tiziana Ottone, Maria Domenica Divona, Terry Karimi, Fabio Ciccarone, Maria Teresa Voso, Grazia Graziani and Isabella Faraoni
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 385-397; DOI: https://doi.org/10.1124/jpet.121.000537
Fletcher, Madeleine M.
1. Open Access
  AM833 Is a Novel Agonist of Calcitonin Family G Protein–Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective Agonists
  Madeleine M. Fletcher, Peter Keov, Tin T. Truong, Grace Mennen, Caroline A. Hick, Peishen Zhao, Sebastian G.B. Furness, Thomas Kruse, Trine R. Clausen, Denise Wootten and Patrick M. Sexton
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 417-440; DOI: https://doi.org/10.1124/jpet.121.000567
Furness, Sebastian G.B.
1. Open Access
  AM833 Is a Novel Agonist of Calcitonin Family G Protein–Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective Agonists
  Madeleine M. Fletcher, Peter Keov, Tin T. Truong, Grace Mennen, Caroline A. Hick, Peishen Zhao, Sebastian G.B. Furness, Thomas Kruse, Trine R. Clausen, Denise Wootten and Patrick M. Sexton
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 417-440; DOI: https://doi.org/10.1124/jpet.121.000567

G

Giansanti, Manuela
1. You have access
  Poly(ADP-Ribose) Polymerase Inhibitors for Arsenic Trioxide–Resistant Acute Promyelocytic Leukemia: Synergistic In Vitro Antitumor Effects with Hypomethylating Agents or High-Dose Vitamin C
  Manuela Giansanti, Antonio De Gabrieli, Salvatore Pasquale Prete, Tiziana Ottone, Maria Domenica Divona, Terry Karimi, Fabio Ciccarone, Maria Teresa Voso, Grazia Graziani and Isabella Faraoni
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 385-397; DOI: https://doi.org/10.1124/jpet.121.000537
Graziani, Grazia
1. You have access
  Poly(ADP-Ribose) Polymerase Inhibitors for Arsenic Trioxide–Resistant Acute Promyelocytic Leukemia: Synergistic In Vitro Antitumor Effects with Hypomethylating Agents or High-Dose Vitamin C
  Manuela Giansanti, Antonio De Gabrieli, Salvatore Pasquale Prete, Tiziana Ottone, Maria Domenica Divona, Terry Karimi, Fabio Ciccarone, Maria Teresa Voso, Grazia Graziani and Isabella Faraoni
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 385-397; DOI: https://doi.org/10.1124/jpet.121.000537

H

Häusler, Stephanie
1. Open Access
  Characterization of Novel Fluorescent Bile Salt Derivatives for Studying Human Bile Salt and Organic Anion Transporters
  Michele Leuenberger, Stephanie Häusler, Vera Höhn, Adriana Euler, Bruno Stieger and Martin Lochner
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 346-357; DOI: https://doi.org/10.1124/jpet.120.000449
Herrington, David
1. You have access
  Chronic Ca²⁺/Calmodulin-Dependent Protein Kinase II Inhibition Rescues Advanced Heart Failure
  Yixi Liu, Qun Shao, Heng-Jie Cheng, Tiankai Li, Xiaowei Zhang, Michael F. Callahan, David Herrington, Dalane Kitzman, David Zhao and Che-Ping Cheng
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 316-325; DOI: https://doi.org/10.1124/jpet.120.000361
Hick, Caroline A.
1. Open Access
  AM833 Is a Novel Agonist of Calcitonin Family G Protein–Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective Agonists
  Madeleine M. Fletcher, Peter Keov, Tin T. Truong, Grace Mennen, Caroline A. Hick, Peishen Zhao, Sebastian G.B. Furness, Thomas Kruse, Trine R. Clausen, Denise Wootten and Patrick M. Sexton
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 417-440; DOI: https://doi.org/10.1124/jpet.121.000567
Hitchcock, Stephen H.
1. You have access
  Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease
  Nicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. Carlton
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Höhn, Vera
1. Open Access
  Characterization of Novel Fluorescent Bile Salt Derivatives for Studying Human Bile Salt and Organic Anion Transporters
  Michele Leuenberger, Stephanie Häusler, Vera Höhn, Adriana Euler, Bruno Stieger and Martin Lochner
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 346-357; DOI: https://doi.org/10.1124/jpet.120.000449
Hosea, Natalie
1. You have access
  Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease
  Nicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. Carlton
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Hou, Zehui
1. You have access
  circ-Keratin 6c Promotes Malignant Progression and Immune Evasion of Colorectal Cancer through microRNA-485-3p/Programmed Cell Death Receptor Ligand 1 Axis
  Zhipeng Jiang, Zehui Hou, Wei Liu, Zhuomin Yu, Zhiqiang Liang and Shuang Chen
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 358-367; DOI: https://doi.org/10.1124/jpet.121.000518

J

Jiang, Lin-shan
1. You have access
  Ginsenoside Ro Ameliorates High-Fat Diet–Induced Obesity and Insulin Resistance in Mice via Activation of the G Protein–Coupled Bile Acid Receptor 5 Pathway
  Lin-shan Jiang, Wei Li, Tong-xi Zhuang, Jie-jing Yu, Shuai Sun, Zheng-cai Ju, Zheng-tao Wang, Li-li Ding and Li Yang
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 441-451; DOI: https://doi.org/10.1124/jpet.120.000435
Jiang, Zhipeng
1. You have access
  circ-Keratin 6c Promotes Malignant Progression and Immune Evasion of Colorectal Cancer through microRNA-485-3p/Programmed Cell Death Receptor Ligand 1 Axis
  Zhipeng Jiang, Zehui Hou, Wei Liu, Zhuomin Yu, Zhiqiang Liang and Shuang Chen
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 358-367; DOI: https://doi.org/10.1124/jpet.121.000518
Johnson, Chad R.
1. You have access
  Novel Antimuscarinic Antidepressant-like Compounds with Reduced Effects on Cognition
  Chad R. Johnson, Brian D. Kangas, Emily M. Jutkiewicz, Gail Winger, Jack Bergman, Andrew Coop and James H. Woods
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 336-345; DOI: https://doi.org/10.1124/jpet.120.000337
Ju, Zheng-cai
1. You have access
  Ginsenoside Ro Ameliorates High-Fat Diet–Induced Obesity and Insulin Resistance in Mice via Activation of the G Protein–Coupled Bile Acid Receptor 5 Pathway
  Lin-shan Jiang, Wei Li, Tong-xi Zhuang, Jie-jing Yu, Shuai Sun, Zheng-cai Ju, Zheng-tao Wang, Li-li Ding and Li Yang
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 441-451; DOI: https://doi.org/10.1124/jpet.120.000435
Jusko, William J.
1. You have access
  Synergistic Pharmacodynamic Effects of Gemcitabine and Fibroblast Growth Factor Receptor Inhibitors on Pancreatic Cancer Cell Cycle Kinetics and Proliferation
  Qingxiang Lin, Zhicheng Qian, William J. Jusko, Donald E. Mager, Wen Wee Ma and Robert M. Straubinger
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 370-384; DOI: https://doi.org/10.1124/jpet.120.000412
Jutkiewicz, Emily M.
1. You have access
  Novel Antimuscarinic Antidepressant-like Compounds with Reduced Effects on Cognition
  Chad R. Johnson, Brian D. Kangas, Emily M. Jutkiewicz, Gail Winger, Jack Bergman, Andrew Coop and James H. Woods
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 336-345; DOI: https://doi.org/10.1124/jpet.120.000337

K

Kangas, Brian D.
1. You have access
  Novel Antimuscarinic Antidepressant-like Compounds with Reduced Effects on Cognition
  Chad R. Johnson, Brian D. Kangas, Emily M. Jutkiewicz, Gail Winger, Jack Bergman, Andrew Coop and James H. Woods
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 336-345; DOI: https://doi.org/10.1124/jpet.120.000337
Kanta, Anne
1. You have access
  Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease
  Nicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. Carlton
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Karimi, Terry
1. You have access
  Poly(ADP-Ribose) Polymerase Inhibitors for Arsenic Trioxide–Resistant Acute Promyelocytic Leukemia: Synergistic In Vitro Antitumor Effects with Hypomethylating Agents or High-Dose Vitamin C
  Manuela Giansanti, Antonio De Gabrieli, Salvatore Pasquale Prete, Tiziana Ottone, Maria Domenica Divona, Terry Karimi, Fabio Ciccarone, Maria Teresa Voso, Grazia Graziani and Isabella Faraoni
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 385-397; DOI: https://doi.org/10.1124/jpet.121.000537
Kaushal, Nidhi
1. You have access
  Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease
  Nicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. Carlton
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Keov, Peter
1. Open Access
  AM833 Is a Novel Agonist of Calcitonin Family G Protein–Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective Agonists
  Madeleine M. Fletcher, Peter Keov, Tin T. Truong, Grace Mennen, Caroline A. Hick, Peishen Zhao, Sebastian G.B. Furness, Thomas Kruse, Trine R. Clausen, Denise Wootten and Patrick M. Sexton
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 417-440; DOI: https://doi.org/10.1124/jpet.121.000567
Kitzman, Dalane
1. You have access
  Chronic Ca²⁺/Calmodulin-Dependent Protein Kinase II Inhibition Rescues Advanced Heart Failure
  Yixi Liu, Qun Shao, Heng-Jie Cheng, Tiankai Li, Xiaowei Zhang, Michael F. Callahan, David Herrington, Dalane Kitzman, David Zhao and Che-Ping Cheng
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 316-325; DOI: https://doi.org/10.1124/jpet.120.000361
Kruse, Thomas
1. Open Access
  AM833 Is a Novel Agonist of Calcitonin Family G Protein–Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective Agonists
  Madeleine M. Fletcher, Peter Keov, Tin T. Truong, Grace Mennen, Caroline A. Hick, Peishen Zhao, Sebastian G.B. Furness, Thomas Kruse, Trine R. Clausen, Denise Wootten and Patrick M. Sexton
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 417-440; DOI: https://doi.org/10.1124/jpet.121.000567

L

Larsen, Bjarne Due
1. You have access
  Comments on “Pharmacological Characterization of Apraglutide a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist for the Treatment of Short Bowel Syndrome”
  Jolanta Skarbaliene, Bjarne Due Larsen, Mark Berner-Hansen and Adam Steensberg
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 369; DOI: https://doi.org/10.1124/jpet.120.000426
Lawrence, Jason
1. You have access
  Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease
  Nicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. Carlton
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Leuenberger, Michele
1. Open Access
  Characterization of Novel Fluorescent Bile Salt Derivatives for Studying Human Bile Salt and Organic Anion Transporters
  Michele Leuenberger, Stephanie Häusler, Vera Höhn, Adriana Euler, Bruno Stieger and Martin Lochner
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 346-357; DOI: https://doi.org/10.1124/jpet.120.000449
Li, Tiankai
1. You have access
  Chronic Ca²⁺/Calmodulin-Dependent Protein Kinase II Inhibition Rescues Advanced Heart Failure
  Yixi Liu, Qun Shao, Heng-Jie Cheng, Tiankai Li, Xiaowei Zhang, Michael F. Callahan, David Herrington, Dalane Kitzman, David Zhao and Che-Ping Cheng
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 316-325; DOI: https://doi.org/10.1124/jpet.120.000361
Li, Wei
1. You have access
  Ginsenoside Ro Ameliorates High-Fat Diet–Induced Obesity and Insulin Resistance in Mice via Activation of the G Protein–Coupled Bile Acid Receptor 5 Pathway
  Lin-shan Jiang, Wei Li, Tong-xi Zhuang, Jie-jing Yu, Shuai Sun, Zheng-cai Ju, Zheng-tao Wang, Li-li Ding and Li Yang
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 441-451; DOI: https://doi.org/10.1124/jpet.120.000435
Liang, Ching Ling
1. Open Access
  Therapeutic Assessment of Combination Therapy with a Neprilysin Inhibitor and Angiotensin Type 1 Receptor Antagonist on Angiotensin II–Induced Atherosclerosis, Abdominal Aortic Aneurysms, and Hypertension
  Yasir Alsiraj, Sean E. Thatcher, Ching Ling Liang, Heba Ali, Mark Ensor and Lisa A. Cassis
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 326-335; DOI: https://doi.org/10.1124/jpet.121.000525
Liang, Zhiqiang
1. You have access
  circ-Keratin 6c Promotes Malignant Progression and Immune Evasion of Colorectal Cancer through microRNA-485-3p/Programmed Cell Death Receptor Ligand 1 Axis
  Zhipeng Jiang, Zehui Hou, Wei Liu, Zhuomin Yu, Zhiqiang Liang and Shuang Chen
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 358-367; DOI: https://doi.org/10.1124/jpet.121.000518
Lin, Qingxiang
1. You have access
  Synergistic Pharmacodynamic Effects of Gemcitabine and Fibroblast Growth Factor Receptor Inhibitors on Pancreatic Cancer Cell Cycle Kinetics and Proliferation
  Qingxiang Lin, Zhicheng Qian, William J. Jusko, Donald E. Mager, Wen Wee Ma and Robert M. Straubinger
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 370-384; DOI: https://doi.org/10.1124/jpet.120.000412
Liu, Wei
1. You have access
  circ-Keratin 6c Promotes Malignant Progression and Immune Evasion of Colorectal Cancer through microRNA-485-3p/Programmed Cell Death Receptor Ligand 1 Axis
  Zhipeng Jiang, Zehui Hou, Wei Liu, Zhuomin Yu, Zhiqiang Liang and Shuang Chen
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 358-367; DOI: https://doi.org/10.1124/jpet.121.000518
Liu, Yixi
1. You have access
  Chronic Ca²⁺/Calmodulin-Dependent Protein Kinase II Inhibition Rescues Advanced Heart Failure
  Yixi Liu, Qun Shao, Heng-Jie Cheng, Tiankai Li, Xiaowei Zhang, Michael F. Callahan, David Herrington, Dalane Kitzman, David Zhao and Che-Ping Cheng
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 316-325; DOI: https://doi.org/10.1124/jpet.120.000361
Liu, Zhenzhen
1. Open Access
  A Novel Integrated Pharmacokinetic-Pharmacodynamic Model to Evaluate Combination Therapy and Determine In Vivo Synergism
  Young Hee Choi, Chao Zhang, Zhenzhen Liu, Mei-Juan Tu, Ai-Xi Yu and Ai-Ming Yu
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 305-315; DOI: https://doi.org/10.1124/jpet.121.000584
Lochner, Martin
1. Open Access
  Characterization of Novel Fluorescent Bile Salt Derivatives for Studying Human Bile Salt and Organic Anion Transporters
  Michele Leuenberger, Stephanie Häusler, Vera Höhn, Adriana Euler, Bruno Stieger and Martin Lochner
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 346-357; DOI: https://doi.org/10.1124/jpet.120.000449

M

Ma, Wen Wee
1. You have access
  Synergistic Pharmacodynamic Effects of Gemcitabine and Fibroblast Growth Factor Receptor Inhibitors on Pancreatic Cancer Cell Cycle Kinetics and Proliferation
  Qingxiang Lin, Zhicheng Qian, William J. Jusko, Donald E. Mager, Wen Wee Ma and Robert M. Straubinger
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 370-384; DOI: https://doi.org/10.1124/jpet.120.000412
Mager, Donald E.
1. You have access
  Synergistic Pharmacodynamic Effects of Gemcitabine and Fibroblast Growth Factor Receptor Inhibitors on Pancreatic Cancer Cell Cycle Kinetics and Proliferation
  Qingxiang Lin, Zhicheng Qian, William J. Jusko, Donald E. Mager, Wen Wee Ma and Robert M. Straubinger
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 370-384; DOI: https://doi.org/10.1124/jpet.120.000412
Mennen, Grace
1. Open Access
  AM833 Is a Novel Agonist of Calcitonin Family G Protein–Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective Agonists
  Madeleine M. Fletcher, Peter Keov, Tin T. Truong, Grace Mennen, Caroline A. Hick, Peishen Zhao, Sebastian G.B. Furness, Thomas Kruse, Trine R. Clausen, Denise Wootten and Patrick M. Sexton
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 417-440; DOI: https://doi.org/10.1124/jpet.121.000567
Monenschein, Holger
1. You have access
  Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease
  Nicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. Carlton
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Mulligan, Victoria J.
1. You have access
  Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease
  Nicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. Carlton
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Murphy, Sean T.
1. You have access
  Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease
  Nicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. Carlton
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438

O

Ottone, Tiziana
1. You have access
  Poly(ADP-Ribose) Polymerase Inhibitors for Arsenic Trioxide–Resistant Acute Promyelocytic Leukemia: Synergistic In Vitro Antitumor Effects with Hypomethylating Agents or High-Dose Vitamin C
  Manuela Giansanti, Antonio De Gabrieli, Salvatore Pasquale Prete, Tiziana Ottone, Maria Domenica Divona, Terry Karimi, Fabio Ciccarone, Maria Teresa Voso, Grazia Graziani and Isabella Faraoni
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 385-397; DOI: https://doi.org/10.1124/jpet.121.000537

P

Page, Keith
1. You have access
  Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease
  Nicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. Carlton
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Powell, Justin
1. You have access
  Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease
  Nicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. Carlton
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Prete, Salvatore Pasquale
1. You have access
  Poly(ADP-Ribose) Polymerase Inhibitors for Arsenic Trioxide–Resistant Acute Promyelocytic Leukemia: Synergistic In Vitro Antitumor Effects with Hypomethylating Agents or High-Dose Vitamin C
  Manuela Giansanti, Antonio De Gabrieli, Salvatore Pasquale Prete, Tiziana Ottone, Maria Domenica Divona, Terry Karimi, Fabio Ciccarone, Maria Teresa Voso, Grazia Graziani and Isabella Faraoni
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 385-397; DOI: https://doi.org/10.1124/jpet.121.000537

Q

Qian, Zhicheng
1. You have access
  Synergistic Pharmacodynamic Effects of Gemcitabine and Fibroblast Growth Factor Receptor Inhibitors on Pancreatic Cancer Cell Cycle Kinetics and Proliferation
  Qingxiang Lin, Zhicheng Qian, William J. Jusko, Donald E. Mager, Wen Wee Ma and Robert M. Straubinger
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 370-384; DOI: https://doi.org/10.1124/jpet.120.000412

R

Rice, Kenner C.
1. You have access
  Brain Concentrations of Methylone and Its Metabolites after Systemic Methylone Administration: Relationship to Pharmacodynamic Effects
  Nicole Centazzo, Michael R. Chojnacki, Joshua S. Elmore, Raider Rodriguez, Teeshavi Acosta, Masaki Suzuki, Kenner C. Rice, Michael H. Baumann and Marta Concheiro
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 398-406; DOI: https://doi.org/10.1124/jpet.121.000531
Rodriguez, Raider
1. You have access
  Brain Concentrations of Methylone and Its Metabolites after Systemic Methylone Administration: Relationship to Pharmacodynamic Effects
  Nicole Centazzo, Michael R. Chojnacki, Joshua S. Elmore, Raider Rodriguez, Teeshavi Acosta, Masaki Suzuki, Kenner C. Rice, Michael H. Baumann and Marta Concheiro
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 398-406; DOI: https://doi.org/10.1124/jpet.121.000531
Russo, Joseph
1. You have access
  Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease
  Nicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. Carlton
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438

S

Schiffer, Hans H.
1. You have access
  Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease
  Nicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. Carlton
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Sexton, Patrick M.
1. Open Access
  AM833 Is a Novel Agonist of Calcitonin Family G Protein–Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective Agonists
  Madeleine M. Fletcher, Peter Keov, Tin T. Truong, Grace Mennen, Caroline A. Hick, Peishen Zhao, Sebastian G.B. Furness, Thomas Kruse, Trine R. Clausen, Denise Wootten and Patrick M. Sexton
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 417-440; DOI: https://doi.org/10.1124/jpet.121.000567
Shao, Qun
1. You have access
  Chronic Ca²⁺/Calmodulin-Dependent Protein Kinase II Inhibition Rescues Advanced Heart Failure
  Yixi Liu, Qun Shao, Heng-Jie Cheng, Tiankai Li, Xiaowei Zhang, Michael F. Callahan, David Herrington, Dalane Kitzman, David Zhao and Che-Ping Cheng
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 316-325; DOI: https://doi.org/10.1124/jpet.120.000361
Sheardown, Steve
1. You have access
  Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease
  Nicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. Carlton
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Skarbaliene, Jolanta
1. You have access
  Comments on “Pharmacological Characterization of Apraglutide a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist for the Treatment of Short Bowel Syndrome”
  Jolanta Skarbaliene, Bjarne Due Larsen, Mark Berner-Hansen and Adam Steensberg
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 369; DOI: https://doi.org/10.1124/jpet.120.000426
Steensberg, Adam
1. You have access
  Comments on “Pharmacological Characterization of Apraglutide a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist for the Treatment of Short Bowel Syndrome”
  Jolanta Skarbaliene, Bjarne Due Larsen, Mark Berner-Hansen and Adam Steensberg
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 369; DOI: https://doi.org/10.1124/jpet.120.000426
Stieger, Bruno
1. Open Access
  Characterization of Novel Fluorescent Bile Salt Derivatives for Studying Human Bile Salt and Organic Anion Transporters
  Michele Leuenberger, Stephanie Häusler, Vera Höhn, Adriana Euler, Bruno Stieger and Martin Lochner
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 346-357; DOI: https://doi.org/10.1124/jpet.120.000449
Straubinger, Robert M.
1. You have access
  Synergistic Pharmacodynamic Effects of Gemcitabine and Fibroblast Growth Factor Receptor Inhibitors on Pancreatic Cancer Cell Cycle Kinetics and Proliferation
  Qingxiang Lin, Zhicheng Qian, William J. Jusko, Donald E. Mager, Wen Wee Ma and Robert M. Straubinger
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 370-384; DOI: https://doi.org/10.1124/jpet.120.000412
Sun, Huikai
1. You have access
  Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease
  Nicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. Carlton
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Sun, Shuai
1. You have access
  Ginsenoside Ro Ameliorates High-Fat Diet–Induced Obesity and Insulin Resistance in Mice via Activation of the G Protein–Coupled Bile Acid Receptor 5 Pathway
  Lin-shan Jiang, Wei Li, Tong-xi Zhuang, Jie-jing Yu, Shuai Sun, Zheng-cai Ju, Zheng-tao Wang, Li-li Ding and Li Yang
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 441-451; DOI: https://doi.org/10.1124/jpet.120.000435
Suzuki, Masaki
1. You have access
  Brain Concentrations of Methylone and Its Metabolites after Systemic Methylone Administration: Relationship to Pharmacodynamic Effects
  Nicole Centazzo, Michael R. Chojnacki, Joshua S. Elmore, Raider Rodriguez, Teeshavi Acosta, Masaki Suzuki, Kenner C. Rice, Michael H. Baumann and Marta Concheiro
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 398-406; DOI: https://doi.org/10.1124/jpet.121.000531

T

Thatcher, Sean E.
1. Open Access
  Therapeutic Assessment of Combination Therapy with a Neprilysin Inhibitor and Angiotensin Type 1 Receptor Antagonist on Angiotensin II–Induced Atherosclerosis, Abdominal Aortic Aneurysms, and Hypertension
  Yasir Alsiraj, Sean E. Thatcher, Ching Ling Liang, Heba Ali, Mark Ensor and Lisa A. Cassis
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 326-335; DOI: https://doi.org/10.1124/jpet.121.000525
Truong, Tin T.
1. Open Access
  AM833 Is a Novel Agonist of Calcitonin Family G Protein–Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective Agonists
  Madeleine M. Fletcher, Peter Keov, Tin T. Truong, Grace Mennen, Caroline A. Hick, Peishen Zhao, Sebastian G.B. Furness, Thomas Kruse, Trine R. Clausen, Denise Wootten and Patrick M. Sexton
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 417-440; DOI: https://doi.org/10.1124/jpet.121.000567
Tu, Mei-Juan
1. Open Access
  A Novel Integrated Pharmacokinetic-Pharmacodynamic Model to Evaluate Combination Therapy and Determine In Vivo Synergism
  Young Hee Choi, Chao Zhang, Zhenzhen Liu, Mei-Juan Tu, Ai-Xi Yu and Ai-Ming Yu
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 305-315; DOI: https://doi.org/10.1124/jpet.121.000584

V

Voso, Maria Teresa
1. You have access
  Poly(ADP-Ribose) Polymerase Inhibitors for Arsenic Trioxide–Resistant Acute Promyelocytic Leukemia: Synergistic In Vitro Antitumor Effects with Hypomethylating Agents or High-Dose Vitamin C
  Manuela Giansanti, Antonio De Gabrieli, Salvatore Pasquale Prete, Tiziana Ottone, Maria Domenica Divona, Terry Karimi, Fabio Ciccarone, Maria Teresa Voso, Grazia Graziani and Isabella Faraoni
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 385-397; DOI: https://doi.org/10.1124/jpet.121.000537

W

Wang, Zheng-tao
1. You have access
  Ginsenoside Ro Ameliorates High-Fat Diet–Induced Obesity and Insulin Resistance in Mice via Activation of the G Protein–Coupled Bile Acid Receptor 5 Pathway
  Lin-shan Jiang, Wei Li, Tong-xi Zhuang, Jie-jing Yu, Shuai Sun, Zheng-cai Ju, Zheng-tao Wang, Li-li Ding and Li Yang
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 441-451; DOI: https://doi.org/10.1124/jpet.120.000435
Winger, Gail
1. You have access
  Novel Antimuscarinic Antidepressant-like Compounds with Reduced Effects on Cognition
  Chad R. Johnson, Brian D. Kangas, Emily M. Jutkiewicz, Gail Winger, Jack Bergman, Andrew Coop and James H. Woods
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 336-345; DOI: https://doi.org/10.1124/jpet.120.000337
Woods, James H.
1. You have access
  Novel Antimuscarinic Antidepressant-like Compounds with Reduced Effects on Cognition
  Chad R. Johnson, Brian D. Kangas, Emily M. Jutkiewicz, Gail Winger, Jack Bergman, Andrew Coop and James H. Woods
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 336-345; DOI: https://doi.org/10.1124/jpet.120.000337
Wootten, Denise
1. Open Access
  AM833 Is a Novel Agonist of Calcitonin Family G Protein–Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective Agonists
  Madeleine M. Fletcher, Peter Keov, Tin T. Truong, Grace Mennen, Caroline A. Hick, Peishen Zhao, Sebastian G.B. Furness, Thomas Kruse, Trine R. Clausen, Denise Wootten and Patrick M. Sexton
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 417-440; DOI: https://doi.org/10.1124/jpet.121.000567

X

Xu, Xiao
1. You have access
  Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease
  Nicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. Carlton
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438

Y

Yang, Li
1. You have access
  Ginsenoside Ro Ameliorates High-Fat Diet–Induced Obesity and Insulin Resistance in Mice via Activation of the G Protein–Coupled Bile Acid Receptor 5 Pathway
  Lin-shan Jiang, Wei Li, Tong-xi Zhuang, Jie-jing Yu, Shuai Sun, Zheng-cai Ju, Zheng-tao Wang, Li-li Ding and Li Yang
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 441-451; DOI: https://doi.org/10.1124/jpet.120.000435
Yu, Ai-Ming
1. Open Access
  A Novel Integrated Pharmacokinetic-Pharmacodynamic Model to Evaluate Combination Therapy and Determine In Vivo Synergism
  Young Hee Choi, Chao Zhang, Zhenzhen Liu, Mei-Juan Tu, Ai-Xi Yu and Ai-Ming Yu
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 305-315; DOI: https://doi.org/10.1124/jpet.121.000584
Yu, Ai-Xi
1. Open Access
  A Novel Integrated Pharmacokinetic-Pharmacodynamic Model to Evaluate Combination Therapy and Determine In Vivo Synergism
  Young Hee Choi, Chao Zhang, Zhenzhen Liu, Mei-Juan Tu, Ai-Xi Yu and Ai-Ming Yu
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 305-315; DOI: https://doi.org/10.1124/jpet.121.000584
Yu, Jie-jing
1. You have access
  Ginsenoside Ro Ameliorates High-Fat Diet–Induced Obesity and Insulin Resistance in Mice via Activation of the G Protein–Coupled Bile Acid Receptor 5 Pathway
  Lin-shan Jiang, Wei Li, Tong-xi Zhuang, Jie-jing Yu, Shuai Sun, Zheng-cai Ju, Zheng-tao Wang, Li-li Ding and Li Yang
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 441-451; DOI: https://doi.org/10.1124/jpet.120.000435
Yu, Zhuomin
1. You have access
  circ-Keratin 6c Promotes Malignant Progression and Immune Evasion of Colorectal Cancer through microRNA-485-3p/Programmed Cell Death Receptor Ligand 1 Axis
  Zhipeng Jiang, Zehui Hou, Wei Liu, Zhuomin Yu, Zhiqiang Liang and Shuang Chen
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 358-367; DOI: https://doi.org/10.1124/jpet.121.000518

Z

Zhang, Chao
1. Open Access
  A Novel Integrated Pharmacokinetic-Pharmacodynamic Model to Evaluate Combination Therapy and Determine In Vivo Synergism
  Young Hee Choi, Chao Zhang, Zhenzhen Liu, Mei-Juan Tu, Ai-Xi Yu and Ai-Ming Yu
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 305-315; DOI: https://doi.org/10.1124/jpet.121.000584
Zhang, Xiaowei
1. You have access
  Chronic Ca²⁺/Calmodulin-Dependent Protein Kinase II Inhibition Rescues Advanced Heart Failure
  Yixi Liu, Qun Shao, Heng-Jie Cheng, Tiankai Li, Xiaowei Zhang, Michael F. Callahan, David Herrington, Dalane Kitzman, David Zhao and Che-Ping Cheng
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 316-325; DOI: https://doi.org/10.1124/jpet.120.000361
Zhao, David
1. You have access
  Chronic Ca²⁺/Calmodulin-Dependent Protein Kinase II Inhibition Rescues Advanced Heart Failure
  Yixi Liu, Qun Shao, Heng-Jie Cheng, Tiankai Li, Xiaowei Zhang, Michael F. Callahan, David Herrington, Dalane Kitzman, David Zhao and Che-Ping Cheng
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 316-325; DOI: https://doi.org/10.1124/jpet.120.000361
Zhao, Peishen
1. Open Access
  AM833 Is a Novel Agonist of Calcitonin Family G Protein–Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective Agonists
  Madeleine M. Fletcher, Peter Keov, Tin T. Truong, Grace Mennen, Caroline A. Hick, Peishen Zhao, Sebastian G.B. Furness, Thomas Kruse, Trine R. Clausen, Denise Wootten and Patrick M. Sexton
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 417-440; DOI: https://doi.org/10.1124/jpet.121.000567
Zhuang, Tong-xi
1. You have access
  Ginsenoside Ro Ameliorates High-Fat Diet–Induced Obesity and Insulin Resistance in Mice via Activation of the G Protein–Coupled Bile Acid Receptor 5 Pathway
  Lin-shan Jiang, Wei Li, Tong-xi Zhuang, Jie-jing Yu, Shuai Sun, Zheng-cai Ju, Zheng-tao Wang, Li-li Ding and Li Yang
  
  Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 441-451; DOI: https://doi.org/10.1124/jpet.120.000435

Main menu

User menu

Search

Index by author

A

Acosta, Teeshavi

Ali, Heba

Alsiraj, Yasir

B

Bartkowski, Darian

Baumann, Michael H.

Bergman, Jack

Berner-Hansen, Mark

Brice, Nicola L.

Burley, J. Russell

C

Callahan, Michael F.

Carlton, Mark B.

Cassis, Lisa A.

Centazzo, Nicole

Chen, Shuang

Chen, Yun

Cheng, Che-Ping

Cheng, Heng-Jie

Cheung, Toni

Choi, Young Hee

Chojnacki, Michael R.

Ciccarone, Fabio

Clausen, Trine R.

Concheiro, Marta

Coop, Andrew

D

Dawson, Lee A.

De Gabrieli, Antonio

Dickson, Louise

Ding, Li-li

Divona, Maria Domenica

E

Elmore, Joshua S.

Ensor, Mark

Euler, Adriana

F

Faraoni, Isabella

Fletcher, Madeleine M.

Furness, Sebastian G.B.

G

Giansanti, Manuela

Graziani, Grazia

H

Häusler, Stephanie

Herrington, David

Hick, Caroline A.

Hitchcock, Stephen H.

Höhn, Vera

Hosea, Natalie

Hou, Zehui

J

Jiang, Lin-shan

Jiang, Zhipeng

Johnson, Chad R.

Ju, Zheng-cai

Jusko, William J.

Jutkiewicz, Emily M.

K

Kangas, Brian D.

Kanta, Anne

Karimi, Terry

Kaushal, Nidhi

Keov, Peter

Kitzman, Dalane

Kruse, Thomas

L

Larsen, Bjarne Due

Lawrence, Jason

Leuenberger, Michele

Li, Tiankai

Li, Wei

Liang, Ching Ling

Liang, Zhiqiang

Lin, Qingxiang